Home / INCA1 Knockout Cell Lines

INCA1 Knockout Cell Lines

Gene: INCA1

Official Full Name: inhibitor of CDK, cyclin A1 interacting protein 1provided by HGNC

Gene Summary: Enables cyclin binding activity; cyclin-dependent protein serine/threonine kinase inhibitor activity; and identical protein binding activity. Acts upstream of or within negative regulation of cyclin-dependent protein serine/threonine kinase activity. Located in cytoplasm and nuclear body. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO16933 INCA1 Knockout cell line (HeLa) Human INCA1 1:3~1:6 Negative Online Inquiry
KO16934 INCA1 Knockout cell line (HEK293) Human INCA1 1:3~1:6 Negative Online Inquiry
KO16935 INCA1 Knockout cell line (A549) Human INCA1 1:3~1:4 Negative Online Inquiry

Background

INCA1 Gene Knockout Cell Lines are specialized cellular models engineered to specifically disrupt the expression of the INCA1 gene, a vital regulator implicated in various biological processes, including cell growth and proliferation. By utilizing CRISPR-Cas9 gene-editing technology, these cell lines provide researchers with a robust platform to study the functional role of INCA1 in cellular pathways and disease mechanisms.

The key functionality of INCA1 Gene Knockout Cell Lines lies in their ability to facilitate gene loss-of-function studies, allowing scientists to observe phenotypic and molecular alterations resulting from the absence of INCA1. This mechanistic insight is invaluable for elucidating its role in oncogenic processes, cell-cycle regulation, and potential therapeutic targets. The knockout strategy not only aids in identifying downstream signaling pathways affected by INCA1 but also enhances our understanding of its interaction with other proteins and cellular substrates.

In scientific and clinical research settings, these knockout models are essential tools for investigating various diseases, including cancer, where dysregulation of cell cycle genes often leads to uncontrolled growth. With applications in drug discovery, biomarker identification, and genetic therapy, the INCA1 Gene Knockout Cell Lines hold significant potential for advancing therapeutic strategies and personalized medicine approaches.

What sets INCA1 Gene Knockout Cell Lines apart from alternative products on the market is their precision and reliability, validated through rigorous quality control and performance assessments. Researchers can easily integrate these models into their studies, benefiting from complete catalogs of detailed characterization data to ensure reproducibility and accuracy in experimental outcomes.

By choosing INCA1 Gene Knockout Cell Lines, researchers and clinicians will enhance their experimental capabilities, gaining critical insights into gene function and disease mechanisms. This product is designed to propel scientific discovery and innovation, making it a valuable asset for any laboratory focused on genetic research.

Our company specializes in providing high-quality biological products, with a commitment to supporting the scientific community through advanced cell line technologies and exceptional customer service.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.